Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer—FIGO 2023 classification-Reference-Cited by-同舟云学术

Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer—FIGO 2023 classification

Published:2024-03-21 Issue:3 Volume:165 Page:1304-1305
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:Intl J Gynecology & Obste

Author:

Mutch David¹,Gaffney David²,Matias‐Guiu Xavier³,Fotopoulou Christina⁴,Concin Nicole⁵⁶,Berek Jonathan S.⁷,

Affiliation:

1. Division of Gynecologic Oncology Washington University School of Medicine St Louis Missouri USA

2. Department of Radiation Oncology University of Utah Salt Lake City Utah USA

3. Department of Pathology, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Investigación Biomédica de BellvitgeHospital U de Bellvitge and Hospital U Arnau de Vilanova Universities of Lleida and Barcelona Barcelona Spain

4. Gynaecological Oncology, Department of Surgery and Cancer Imperial College London London UK

5. Department of Obstetrics and Gynecology Medical University of Innsbruck Innsbruck Austria

6. Kliniken Essen‐ Mitte Essen Germany

7. Stanford University School of Medicine, Stanford Women's Cancer Center Stanford Cancer Institute Stanford California USA

Publisher

Wiley

Link

https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/ijgo.15478

Reference16 articles.

1. Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer—FIGO 2023 classification

2. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging

3. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual

4. Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas